What Happened?
Philadelphia, PA-based Aro Biotherapeutics Appointed Sukumar Sakamuri as Chief Technology Officer
About the Company
Based in Philadelphia, Aro Biotherapeutics is a biotechnology company pioneering the development of tissue-targeted genetic medicines with a platform based on a proprietary protein technology called Centyrins. The company is developing a wholly-owned pipeline of Centyrin-based therapeutic candidates and is working with industry partners to leverage Centyrins for tissue-specific targeting of therapeutics for a diverse set of diseases.
About the Person
Sukumar Sakamuri is Chief Technology Officer at Aro Biotherapeutics. Previously, Sukumar held various senior IT leadership roles in the industry.
Info Source
News
Short Profile